Stay updated on Derazantinib in Advanced Cholangiocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The clinical trial record for the derazantinib study appears unchanged.
    Difference
    0.1%
    Check dated 2026-11-16T13:25:12.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the completed Phase II derazantinib study record for advanced intrahepatic cholangiocarcinoma, with study details, results measures, participant criteria, and research locations.
    Difference
    75%
    Check dated 2026-11-09T13:24:08.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden response.
    Difference
    0.2%
    Check dated 2026-11-02T13:14:30.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says federal agencies are adopting the term “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T15:16:52.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2. The page otherwise continues to display a 403 error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-19T14:52:44.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer revision number advanced from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T16:00:58.000Z thumbnail image

Stay in the know with updates to Derazantinib in Advanced Cholangiocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.